Health Holland Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2019
NCT03983603
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Health Holland | TKI Life Sciences and Health (LSH)

Active Ingredients

Drugs in Other Trials (1)

stanols (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 2
  • # of Trial APIs: 1